Inventprise, a Redmond, Wash.–based biotechnology company developing vaccines for infectious diseases, is laying off 76 workers, according to a new filing from the Washington Employment Security Department.
GeekWire has reached out to the company for additional details.
The layoffs impact employees across the company’s Redmond and Woodinville facilities, as well as some remote workers. The first separations are effective Dec. 31.
Job titles affected span a wide range of roles, including manufacturing, quality control, R&D, and technical staff, according to the filing.
The company has nearly 200 employees, according to LinkedIn.
Founded in 2012, Inventprise focuses on addressing global health challenges in low- and middle-income countries. Its pipeline includes lead candidate IVT-PCV-25, a pneumococcal conjugate vaccine candidate that is in Phase 2 trials, according to the company’s website.
Inventprise was founded by Dr. Subhash Kapre, who previously worked on vaccine initiatives with the Gates Foundation. The Seattle-based foundation has provided more than $13 million to Inventprise.
Kapre is currently chairman of Inventprise, which is led by CEO Yves Leurquin, a former Takeda exec who joined the company in 2021.
